British Journal of Clinical Pharmacology

Cover image for Vol. 81 Issue 5

Edited By: A.F. Cohen (Editor-in-Chief), A. de Boer (European Editor), A. Ferro (Reviews Editor), A. Gilchrist (Online Editor), G. Isbister (Australasian Editor), S. Ross (Education Editor) and A. Webb (European Editor)

Impact Factor: 3.878

ISI Journal Citation Reports © Ranking: 2014: 46/255 (Pharmacology & Pharmacy)

Online ISSN: 1365-2125

Associated Title(s): British Journal of Pharmacology, Pharmacology Research & Perspectives


We have collated below a selection of top cancer pharmacology articles published in BJCP (between February and September 2011). All articles are available FREE.

A mechanism-based model for the population pharmacokinetics of free and bound aflibercept in healthy subjects
Hoai-Thu Thai, Christine Veyrat-Follet, Nicole Vivier, Catherine Dubruc, Gerard Sanderink, France Mentré and Emmanuelle Comets

Licensing and labelling of drugs in a paediatric oncology ward
Henk van den Berg and Nanda Tak

Population pharmacokinetic analysis of sorafenib in patients with solid tumours
Lokesh Jain, Sukyung Woo, Erin R. Gardner, et al

Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
Sunil M. Shah, Iain M. Carey, Christopher G. Owen, Tess Harris, Stephen DeWilde and Derek G. Cook

A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours
Xuexin He, Su Li, He Huang, Zhiming Li, Likun Chen, Sheng Ye, Jiajia Huang, Jing Zhan and Tongyu Lin

Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients
Marie-Christine Etienne-Grimaldi, Patricia Formento, et al

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients
Joanne S. L. Lim, Xiang A. Chen, Onkar Singh, Yoon S. Yap, Raymond C. H. Ng, Nan S. Wong, Mabel Wong, Edmund J. D. Lee and Balram Chowbay

Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects
Richat Abbas, Bruce A. Hug, Cathie Leister, Jaime Burns and Daryl Sonnichsen

Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours
Milena Gusella, Felice Pasini, Caterina Bolzonella, et al

Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
Tiphaine Adam de Beaumais, May Fakhoury, Yves Medard, Said Azougagh, Daolun Zhang, Karima Yakouben and Evelyne Jacqz-Aigrain

Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia
Alex Bogason, Angelica L. Quartino, Pierre Lafolie, Michèle Masquelier, Mats O. Karlsson, Christer Paul, Astrid Gruber and Sigurd Vitols

Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide
Sophie Callies, Valérie André, Bharvin Patel, David Waters, Paul Francis, Michael Burgess and Michael Lahn

Recent developments in prostate cancer biomarker research: therapeutic implications
Sujitra Detchokul and Albert G. Frauman